Ghost Fitness/Omega-3/Does krill oil reduce plaque in arteries?
Does krill oil reduce plaque in arteries?
The short answer
No, on two grounds. The empty file: no trial has imaged arterial plaque in people taking krill oil, and the one omega-3 plaque trial used four grams a day of prescription EPA. The dose problem: a krill capsule carries 100 to 200mg of EPA and DHA, so reaching that dose would take twenty to forty capsules. Krill's own file is small lipid and joint trials, with no plaque claim, and a statin regresses plaque.
- The plaque file for krillempty: no imaging trial at any dose
- The one omega-3 plaque trialfour grams of prescription EPA a day: twenty to forty krill capsules' worth
- A krill capsule100 to 200mg of EPA and DHA in a phospholipid form; the heart claim at two or three capsules
- The comparisonone standard fish oil softgel at 300mg of EPA and DHA reaches the heart claim at a fraction of krill's price per milligram
Our brand: the worked example on this page
Futuro Labs Omega 3 Fish Oil
- 17p a day
- 90 softgels, 1 softgel daily
- Lab tested
- Made in the UK
The heart claim in one softgel, at a fraction of krill's price per milligram: Futuro Labs Omega 3 Fish Oil on Amazon UK, 1 softgel with food, 180mg EPA and 120mg DHA, 90 for £14.99 at 17p. Full label breakdown. The fish oil plaque page is here; the krill shelf on the pharmacy shelf page.
No on an empty file, and the dose problem that makes even the fish oil answer unreachable with krill
Does krill oil reduce plaque in arteries is answered no on two grounds, one shared with fish oil and one that is krill's own. The shared ground is the empty file: no trial has imaged arterial plaque in people taking krill oil at any dose, by CT, ultrasound or any other method, so the question has no evidence of its own to be answered from, and the nearest evidence, the one omega-3 plaque imaging trial, used four grams a day of purified prescription EPA ethyl ester for eighteen months in patients with raised triglycerides on statins and found low-attenuation coronary plaque reduced on CT, a prescription-dose finding in a high-risk population that the fish oil plaque page describes and that a supplement of any kind has never reproduced, the outcome trials at a gram a day having found no reduction in events and UK guidance not offering omega-3 for cardiovascular prevention. Krill's own ground is the dose problem, and it is why the krill question is easier to answer than the fish oil one: a krill oil capsule carries around 100 to 200mg of EPA and DHA, bound to phospholipids and accompanied by the astaxanthin that gives the oil its colour, against a standard fish oil softgel's 300mg and a concentrate's gram, so that reaching the plaque trial's four grams of EPA with krill would take twenty to forty capsules a day, a shelf of krill for a prescription's worth of EPA, at a price per milligram that is already the highest on the omega-3 shelf, the pharmacy shelf page's krill arithmetic, and no trial has ever given krill at anything like that dose because nobody would take it.
Krill's own file, which is small and about other things, the claim it may carry, the reader with plaque, and the question filed
Krill's own file is small and about other things. The lipid trials: a handful of small studies report krill oil lowering triglycerides and modestly changing other lipids at one to three grams of krill oil a day, effects consistent with its EPA and DHA content and no larger per milligram than fish oil's, the phospholipid form's better absorption being real in some studies and not translating into a plaque or outcome finding anywhere. The joint trials: small studies reporting less joint pain and stiffness with krill oil over weeks in people with arthritis, the krill pages' file, small and unreplicated at scale and belonging to the joint pages rather than the artery. The astaxanthin: a carotenoid antioxidant with laboratory activity and no claim, no plaque trial and no reason to expect one at the milligram in a capsule. What krill may carry on the register is the same sentence any omega-3 carries, EPA and DHA contribute to the maintenance of normal heart function at 250mg a day combined, reached by two or three krill capsules or by one standard fish oil softgel at a fraction of the price per milligram, and no plaque, artery, cholesterol or prevention sentence, so a krill label may not print any of them and a krill oil sold for arteries has stepped outside the register as far as a fish oil sold for the same has. The reader with plaque on a scan has the same answer krill or not: a cardiologist and a lipid clinic, a statin at the intensity that regresses and stabilises plaque, blood pressure control and no smoking, and an omega-3, if any, by the oily-fish audit for the maintenance claim, in whichever form the reader prefers, the fish oil softgel being the cheaper form of the same 250mg. The question filed: no plaque trial of krill at any dose, the one omega-3 plaque trial at a prescription dose that krill's capsule size makes unreachable, a small file on lipids and joints, the heart maintenance sentence at two or three capsules and no plaque claim, with the worked example being the heart claim in one fish oil softgel at a fraction of krill's price, £14.99 for 90 at 17p.
| The item | The finding | The consequence |
|---|---|---|
| The plaque file for krill | No imaging trial at any dose | Nothing to answer from |
| The one omega-3 plaque trial | Four grams of prescription EPA for eighteen months in high-risk patients on statins | A prescription finding; not a supplement's |
| The dose problem | A krill capsule carries 100 to 200mg of EPA and DHA | Twenty to forty capsules to imitate the trial; nobody has |
| Krill's own file | Small lipid trials; small joint trials; astaxanthin with no claim | About other things |
| The claim krill may carry | Maintenance of normal heart function at 250mg combined | Two or three capsules; one fish oil softgel does it cheaper |
| The reader with plaque | A cardiologist, a lipid clinic, a statin | Not a shelf, krill or otherwise |
The verdict, an empty file, a dose that krill cannot reach, and a statin for the artery
Does krill oil reduce plaque in arteries: no, on an empty file, since no trial has imaged plaque in people taking krill oil at any dose, and on a dose problem, since the one omega-3 plaque trial used four grams a day of purified prescription EPA in high-risk patients on statins and a krill capsule carries 100 to 200mg of EPA and DHA, so imitating that trial would take twenty to forty capsules a day that nobody has ever tested, with krill's own file being small trials on lipids and joints, the only sentence it may carry being the heart maintenance claim at 250mg combined that one fish oil softgel reaches at a fraction of the price, and the reader with plaque on a scan having a cardiologist and a statin rather than any shelf. The heart claim in one softgel: Futuro Labs Omega 3 Fish Oil, one with food, 180mg EPA and 120mg DHA, 90 for £14.99 at 17p a day.
What to check on the label
- Know the krill plaque file is empty: no imaging trial at any dose.
- Do the dose arithmetic: twenty to forty capsules to imitate the prescription trial.
- Read krill's own file: small lipid and joint trials, nothing arterial.
- Reach the heart claim cheaply: one fish oil softgel, or two or three krill capsules.
- Send plaque to a cardiologist: a statin regresses it.
Our brand
The worked example: Futuro Labs Omega 3 Fish Oil
Futuro Labs Omega 3 Fish Oil: 1 softgel daily with food, 1000mg fish oil providing 180mg EPA and 120mg DHA (300mg combined), 90 softgels for £14.99, 17p a day, lab-tested purity, UK GMP made. Gelatin shell, so not vegetarian.
- Fish oil per softgel
- 1000mg
- EPA / DHA per softgel
- 180mg / 120mg (300mg combined)
- Serving
- 1 softgel a day
- Bottle
- 90 softgels, 90 days
- Price
- £14.99 (17p a day)
- Softgel
- mini softgel, no fishy taste
Questions people also ask
Is krill oil good for clogged arteries?
No evidence says so: no trial has imaged arterial plaque in people taking krill oil at any dose, the one omega-3 plaque trial used four grams of prescription EPA in high-risk patients on statins, and reaching that dose with krill's 100 to 200mg capsules would take twenty to forty a day, which nobody has tested.
How much EPA and DHA is in a krill oil capsule?
Around 100 to 200mg combined, bound to phospholipids and accompanied by astaxanthin, against a standard fish oil softgel's 300mg and a concentrate's gram, so krill reaches the 250mg heart claim at two or three capsules and is the most expensive omega-3 on the shelf per milligram.
Does krill oil lower cholesterol or clean arteries?
Small trials report krill oil lowering triglycerides and modestly changing other lipids at one to three grams of krill oil a day, effects no larger per milligram than fish oil's and never translated into a plaque or outcome finding, and no cholesterol, artery or prevention claim exists for krill on the register.
Is krill oil better than fish oil for the heart?
Not on any outcome: the phospholipid form's better absorption in some studies has not produced a heart-prevention or plaque finding, the register's heart sentence at 250mg combined is the same for both and reached far more cheaply by a fish oil softgel, and UK guidance does not offer omega-3 of any kind for cardiovascular prevention.
What should someone with plaque on a scan take?
What the cardiologist and lipid clinic prescribe, a statin at the intensity that regresses and stabilises plaque, blood pressure control and no smoking, with an omega-3 by the oily-fish audit for the maintenance claim only if the plate is low in fish, in the cheaper fish oil form rather than krill.
Sources
- Comparative research on krill oil versus fish oil: phospholipid-form omega-3 with modest EPA and DHA content per capsule, and bioavailability claims that remain debated. PubMed record
- The plaque imaging trial of prescription EPA: four grams a day of purified EPA ethyl ester for eighteen months in patients with raised triglycerides on statins reduced low-attenuation coronary plaque volume on CT against a mineral oil placebo, a prescription-dose finding in a high-risk population with no supplement-dose plaque regression evidence. PubMed record
- The large cardiovascular outcome trials of omega-3: around a gram a day of EPA and DHA in primary-prevention populations produced no meaningful reduction in major cardiovascular events, while four grams of purified EPA in people with raised triglycerides on statins reduced events in one large trial, so the supplement-dose story is maintenance and the treatment-dose story is a prescription. PubMed record
- EFSA Panel on Dietetic Products. Scientific opinion on the substantiation of health claims related to EPA and DHA and normal function of the heart (250mg daily condition of use). EFSA Journal 2010;8(10):1796. https://www.efsa.europa.eu/en/efsajournal/pub/1796